Patent details

EP3280416 Title: DOSING REGIMEN FOR MISSED DOSES FOR LONG-ACTING INJECTABLE PALIPERIDONE ESTERS

  • Data
  • Documents

Basic Information

Publication number:
EP3280416
PCT Application Number:
US2016024841
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP167770585
PCT Publication Number:
WO2016164218
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
DOSING REGIMEN FOR MISSED DOSES FOR LONG-ACTING INJECTABLE PALIPERIDONE ESTERS
French Title of Invention:
SCHÉMA DE TRAITEMENT EN CAS DE DOSES OUBLIÉES POUR DES ESTERS DE PALIPÉRIDONE INJECTABLES À ACTION PROLONGÉE
German Title of Invention:
DOSIERSCHEMA FÜR VERPASSTE DOSEN FÜR LANGWIRKENDE INJIZIERBARE PALIPERIDONESTER
SPC Number:

Dates

Filing date:
30/03/2016
Grant date:
22/04/2020
EP Publication Date:
14/02/2018
PCT Publication Date:
13/10/2016
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
22/04/2020
EP B1 Publication Date:
22/04/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
30/03/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
19/07/2021
 
 

Name:
Janssen Pharmaceutica NV
Address:
Turnhoutseweg 30, 2340 Beerse, Belgium (BE)

History of Owners

From:
12/02/2021
To:
19/07/2021

Name:
Janssen Pharmaceutica NV
Address:
Turnhoutseweg 30, 2340 Beerse, Belgium (BE)

From:
15/04/2020
To:
12/02/2021

Name:
Janssen Pharmaceuticals, Inc.
Address:
1125 Trenton-Harbourton Road, Titusville, NJ 08560, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
27/04/2020
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
GOPAL, Srihari
Address:
United States (US)

2

Name:
SAMTANI, Mahesh Narain
Address:
United States (US)

3

Name:
RUSSU, Alberto
Address:
Belgium (BE)

4

Name:
RAVENSTIJN, Paulien Gerarda Maria
Address:
Belgium (BE)

Priority

1

Priority Number:
201562144054 P
Priority Date:
07/04/2015
Priority Country:
United States (US)

2

Priority Number:
201562162596 P
Priority Date:
15/05/2015
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/00; A61K 9/10; A61K 31/519; A61P 25/18; A61P 25/24;

Publication

Bulletin

Bulletin Heading:
CO
Bulletin edition number:
2021/09
Publication date:
03/08/2021
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

European Patent Bulletin

1

Issue number:
202017
Publication date:
22/04/2020
Description:
Grant (B1)

2

Issue number:
202021
Publication date:
20/05/2020
Description:
Application number/publication number of the divisional application (Art. 76) changed

3

Issue number:
202111
Publication date:
17/03/2021
Description:
Transfer of Rights

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of ownership
Deed Number:
RC20210000297A
Date Registered:
19/07/2021
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
OFFICE FREYLINGER S.A.
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
Janssen Pharmaceutica NV
Address:
Turnhoutseweg 30, 2340 Beerse, Belgium (BE)
Name:
Address:

Annual Fees

Annual Fee Due Date:
31/03/2026
Annual Fee Number:
11
Annual Fee Amount:
148 Euro
Expected Payer:
Last Annual Fee Payment Date:
13/03/2025
Last Annual Fee Paid Number:
10
Last Annual Fee Paid Amount:
131 Euro
Payer:
CPA GLOBAL THE IP PLATFORM